1 / 5

Lung Cancer Diagnosis and Therapeutics Size, Competitive Analysis, Share, Forecast- 2018-2023

Lung Cancer Diagnosis and Therapeutics Size, Competitive Analysis, Share, Forecast- 2018-2023

preeti18
Download Presentation

Lung Cancer Diagnosis and Therapeutics Size, Competitive Analysis, Share, Forecast- 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research Lung Cancer Diagnosis and Therapeutics Size, Competitive Analysis, Share, Forecast- 2018-2023 Request a Free Sample @ https://www.omrglobal.com/request-sample/lung-cancer- diagnostics-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global lung cancer diagnostics market is anticipated to grow at a CAGR of 7.4% by 2023. Lung cancer occurs when cells of the lung become abnormal and begin to grow out of control. As more cancer cells develop, they form into a tumor and spread to other areas of the body. There are two types of lung cancer; Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC). Several factors such as pollution, smoking, passive smoking and other factors cause lunch cancer. There are several factors that are being considered for the cause of the lung cancer such as rising pollution due to the amount of carbon particles inhaled by humans. Robust healthcare expenditure within the developed countries, increasing pollution, Government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the growth of the market. Several signs and symptoms of lung cancer include coughing up blood, weight loss, chest pain, shortness of breath and others. Get Free Sample Copy @https://www.omrglobal.com/request-sample/lung-cancer- diagnostics-market The lung cancer diagnostics and therapeutics market has been segmented into by type, by treatment, by diagnosis, by stages, and by end user. On the basis type, the market has been bifurcated into non-small cell lung cancer and small cell lung cancer. According to therapy, the market has been bifurcated into chemotherapy, targeted therapy, immunotherapy, radiation therapy and others. Based on diagnostics, the market has been bifurcated into CT-scan, X-rays, lung cancer screening, needle biopsy, bronchoscopy, sputum cytology and others On the basis of end user, the market has been bifurcated into multispecialty hospitals and cancer research centers. Browse for Full Report Description@https://www.omrglobal.com/industry-reports/lung- cancer-diagnostics-market MARKET SEGMENTATION GLOBAL LUNG CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY TYPE NON-SMALL CELL LUNG CANCER ADENOCARCINOMAS

  3. BRONCHIOLOALVEOLAR CARCINOMA SQUAMPOUS CELL CARCINOMA LARGE CELL CARCINOMAS SMALL CELL LUNG CANCER GLOBAL LUNG CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY THERAPY CHEMOTHERAPY TARGETED THERAPY IMMUNOTHERAPY RADIATION THERAPY OTHERS GLOBAL LUNG CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY DIAGNOSIS CT SCAN X-RAYS LUNG CANCER SCREENING BRONCHOSCOPY SPUTUM CYTOLOGY OTHERS GLOBAL LUNG CANCER DIAGNOSIS AND THERAPEUTICS MARKET, BY END USER MULTISPECIALITY HOSPITALS CANCER RESEARCH CENTERS COMPETITIVE LANDSCAPE STRATEGY ANALYSIS KEY COMPANY ANALYSIS REGIONAL ANALYSIS NORTH AMERICA UNITED STATES CANADA EUROPE

  4. UNITED KINGDOM FRANCE GERMANY ITALY SPAIN REST OF EUROPE ASIA PACIFIC INDIA CHINA JAPAN REST OF THE WORLD COMPANY PROFILES ABBVIE ARQULE INC. ASTRAZENECA PLC BAYER BOEHRINGER . BRISTOL-MYERS SQUIBB CELGENE DAIICHI SANKYO CO. LTD. EISAI ELI LILLY AND COMPANY GENENTECH GLAXOSMITH MERCK & CO. INC. NOV PFIZER QIAGEN N.V. COMPANY PHARMACYCLICS ROCHE SANOFI TEVA PHARMACEUTICALS VENTANA VALEANT PHARMACEUTICALS INC.

  5. VARIAN MEDICAL SYSTEMS INC. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lung-cancer-diagnostics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related